FindMyKOL

Navin Kapur, MD

Enriched profile

Chief Medical and Scientific Officer, Abiomed · Abiomed

ORCID↗NPI↗
✓ Itemized profile
Region🇺🇸 Baltimore, MD · Northeast · United StatesSpecialtyCardiovascular DiseaseFocusMechanical Circulatory Support Devices+4
Active KOLFindMyKOL type: EliteLatest publication2026Online presenceverified 2026Payments2021–2025NIH fundingNone on fileWhy? →

Navin Kapur is Chief Medical and Scientific Officer, Abiomed at Abiomed. OpenAlex indexes 762 publications with 22,371 citations (h-index 70); ClinicalTrials.gov lists 5 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Cardiovascular Disease profiles in the FindMyKOL directory.

Data verified 28 Oct 2026

Overview

Updated 30 Oct 2026

Navin Kapur, M.D., is Chief Medical and Scientific Officer, Abiomed. The public record shows 762 publications with 22,371 citations (h-index 70), centered on Mechanical Circulatory Support Devices, Acute Myocardial Infarction Research, Respiratory Support and Mechanisms. It also documents an investigator role on 5 registered clinical trials, industry payments reported by 25 companies.

  • Most recent indexed publication: 2026 · Journal of the American Heart Association
  • Top research focus: Mechanical Circulatory Support Devices
  • 5 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 25 companies

Generated from the cited public record · current as of 30 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Heart Failure2 trialsShock2 trialsShock, Cardiogenic2 trialsCoronary Artery Disease / ACS1 trialMyocardial Infarction1 trialST Elevation Myocardial Infarction1 trialInfarction1 trial

Research focus

OpenAlex concept fingerprint
Mechanical Circulatory Support DevicesAcute Myocardial Infarction ResearchRespiratory Support and MechanismsTakotsubo Cardiomyopathy and Associated PhenomenaHeart Failure Treatment and Management

Drugs & molecules

across trials, industry payments and publications
Xareltogeneric · RivaroxabanClinical trials—Industry payments7Publications—Entrestogeneric · Sacubitril / valsartanClinical trials—Industry payments6Publications—Repathageneric · EvolocumabClinical trials—Industry payments6Publications—Leqviogeneric · InclisiranClinical trials—Industry payments5Publications—Ozempicgeneric · SemaglutideClinical trials—Industry payments5Publications—Eliquisgeneric · ApixabanClinical trials—Industry payments3Publications—NirmatrelvirClinical trials—Industry payments3Publications—RimegepantClinical trials—Industry payments3Publications—Injectafergeneric · Ferric carboxymaltoseClinical trials—Industry payments1Publications—Jardiancegeneric · EmpagliflozinClinical trials—Industry payments1Publications—Kengrealgeneric · CangrelorClinical trials—Industry payments1Publications—Nexletolgeneric · Bempedoic acidClinical trials—Industry payments1Publications—

Works with

trial sponsors and companies reporting payments
AbiomedClinical trials—Industry payments256LivaNova USA, Inc.Clinical trials—Industry payments10ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)Clinical trials—Industry payments8Janssen Pharmaceuticals, IncClinical trials—Industry payments7Novartis Pharmaceuticals CorporationClinical trials—Industry payments7Amgen Inc.Clinical trials—Industry payments6ZOLL Circulation IncClinical trials—Industry payments6Edwards Lifesciences CorporationClinical trials—Industry payments5Novo Nordisk IncClinical trials—Industry payments5Boston Scientific CorporationClinical trials—Industry payments4Pfizer Inc.Clinical trials—Industry payments4Abiomed Inc.Clinical trials3Industry payments—ShockWave Medical, IncClinical trials—Industry payments3Abbott LaboratoriesClinical trials—Industry payments2Getinge USA Sales, LLCClinical trials—Industry payments2Medtronic, Inc.Clinical trials—Industry payments2Tufts Medical CenterClinical trials2Industry payments—AngioDynamics, Inc.Clinical trials—Industry payments1AstraZeneca Pharmaceuticals LPClinical trials—Industry payments1Boehringer Ingelheim Pharmaceuticals, Inc.Clinical trials—Industry payments1Cardiva Medical, Inc.Clinical trials—Industry payments1Chiesi USA, Inc.Clinical trials—Industry payments1Daiichi Sankyo Inc.Clinical trials—Industry payments1Esperion Therapeutics, Inc.Clinical trials—Industry payments1MY01 Inc.Clinical trials—Industry payments1Teleflex LLCClinical trials—Industry payments1

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
762publications

Distinct works indexed by OpenAlex, matched via ORCID; 50 in PubMed.

22,371citations

Total citations across indexed works.

70h-index

Hirsch index (OpenAlex). i10-index 242.

Clinical & industry

trials, payments and federal funding
5clinical trials

Investigator role on registered studies.

View trials ↓
25companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
0NIH grants

Federally funded research awards.

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 30 Oct 2026

Listed as an investigator on 5 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 30 Oct 2026

25 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Publications

Updated 30 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Network

Updated 30 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Daniel Burkhoff164Arthur Reshad Garan119Shashank S. Sinha116Manreet Kaur Kanwar115MICHELE L. ESPOSITO92Jaime Hernández-Montfort87Richard H. Karas78Xiaoying Qiao74Claudius Mahr67Rachna Kataria64Lara A. Reyelt58Kevin Morine56Katherine L. Thayer55Elric Zweck55Lija Swain54Kay D. Everett53Jacob Abraham52Shiva Annamalai51Mohit Pahuja50Vikram Paruchuri50NEIL M. HARWANI48Michael S. Kiernan45Van‐Khue Ton44David D. DeNofrio44Carey D. Kimmelstiel42Shreyas Bhave41Saraschandra Vallabhajosyula40Vanessa L. Blumer39Esther Vorovich38Paavni Sangal37Duc Thinh Pham37Shelley Anne Hall35Borui Li35William W. O’Neill35Song Li34Karol D. Walec33Gavin Hickey32PETER S. NATOV31Wissam I. Khalife30Jaime Hernandez Montfort29

Online presence

Updated 30 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/navin-kapur-md

    verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 30 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record

Editorial & leadership roles

journal and society appointments
  • Executive Director

    Cardiovascular Center for Research and Innovation (CVCRI), Tufts Medical Center

    2025
    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →tuftsmedicine.org ↗
  • Member

    American Society for Clinical Investigation

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →esc365.escardio.org ↗
  • Founder

    Cardiogenic Shock Working Group

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →abiomed.com ↗
  • Founding director

    Robert Kung combined Interventional Heart Failure fellowship program

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →abiomed.com ↗

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution
  • Professor

    Tufts University School of Medicine, Boston (former, prior to joining Abiomed)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →abiomed.com ↗

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.